24/05/2017 - 06:29

Global pharma heavyweight joins Analytica board

24/05/2017 - 06:29

Bookmark

Upgrade your subscription to use this feature.

Analytica have appointed a global heavyweight in the pharmaceutical industry to its board of directors as they gear up for the international launch of an innovative medical device that combats urinary incontinence. Dr Peter B. Corr, the former head of R&D at Pfizer, has joined the Analytica board, strengthening ties he already has as a significant shareholder.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options